Clinical Study
Characteristics and Patterns of Metastatic Disease from Chordoma
Table 2
Survival distribution stratified by presence of metastatic disease.
(a) Case processing summary of patients included in analysis |
| Metastasis | Total | of events | Censored | | Percent |
| No | 150 | 63 | 87 | 58.0% | Yes | 27 | 22 | 5 | 18.5% |
| Overall | 177 | 85 | 92 | 52.0% |
|
|
(b) Overall statistical comparison and test of equality of survival distributions |
| | Chi-Square | df | Sig. |
| Log rank (Mantel-Cox) | 3.682 | 1 | 0.055 |
|
|
(c) Means and medians for survival time. Estimation is limited to the largest survival time if it is censored |
| Metastasis | Mean | | Median | | | 95% Conf. interval | | | | 95% Conf. interval | Estimate | Std. error | Lower bound | Upper bound | | Estimate | Std. error | Lower bound | Upper bound |
| No | 188.5 | 13.9 | 161.3 | 215.6 | | 159.3 | 18.1 | 123.9 | 194.6 | Yes | 134.2 | 20.6 | 93.8 | 174.6 | | 130.4 | 9.7 | 111.4 | 149.5 |
| Overall | 177.8 | 12.5 | 153.3 | 202.2 | | 140.5 | 12.7 | 115.7 | 165.3 |
|
|